Serina Therapeutics appoints Trevi CCO Farrell Simon to board

Reuters2026/07/22 20:39

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Serina Therapeutics named Farrell Simon to its board, effective immediately.
Simon will join the audit committee, plus the compensation committee.
He is chief commercial officer at Trevi Therapeutics, leading commercial strategy, lifecycle management, pre-launch planning, business development.
Previously held senior commercial, strategic leadership roles at Pfizer, including Biopharma chief of staff.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607221630PRIMZONEFULLFEED9766427) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Serina Therapeutics appoints Trevi CCO Farrell Simon to board

You may also like

Crypto prices